108 related articles for article (PubMed ID: 3120070)
1. Treatment of excessive thrombocythemia in chronic myeloid leukemia by thrombocytopheresis and intravenous Thio-TEPA.
Renner D; Queisser U; Martinez C; Queisser W
Onkologie; 1987 Oct; 10(5):324-6. PubMed ID: 3120070
[No Abstract] [Full Text] [Related]
2. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic thrombocytopheresis in a case of primary thrombocythemia (author's transl)].
Suzuki K; Adachi H; Senju O; Sano M; Nozu T; Nunoue N; Tsuruoka N; Shimizu M; Kazama K; Ajiri T; Ide T; Kikuchi K; Sano K
Rinsho Ketsueki; 1982 Feb; 23(2):215-23. PubMed ID: 7098013
[No Abstract] [Full Text] [Related]
4. Megakaryocyte DNA content and platelet formation in rats after a sublethal dose of thio-TEPA.
Tanum G
Exp Hematol; 1986 Mar; 14(3):202-6. PubMed ID: 3081360
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic plateletpheresis in thombocythemia.
Panlilio AL; Reiss RF
Transfusion; 1979; 19(2):147-52. PubMed ID: 432925
[TBL] [Abstract][Full Text] [Related]
6. Therapy of essential thrombocythemia with thiotepa and chlorambucil.
Case DC
Blood; 1984 Jan; 63(1):51-4. PubMed ID: 6418235
[TBL] [Abstract][Full Text] [Related]
7. The role of blood component removal in essential and reactive thrombocytosis.
Greist A
Ther Apher; 2002 Feb; 6(1):36-44. PubMed ID: 11886575
[TBL] [Abstract][Full Text] [Related]
8. Platelet apheresis for extreme thrombocytosis in an 11-year-old girl with CML.
McCarthy LJ; Graves VL; Eigen H; McGuire WA
Transfus Med; 1991 Sep; 1(3):187-9. PubMed ID: 9259847
[TBL] [Abstract][Full Text] [Related]
9. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
Jootar S
Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
[TBL] [Abstract][Full Text] [Related]
10. [Effect of cystamine on cytogenetic changes in bone marrow cells and lymphocytes of the peripheral blood in patients with bronchial cancer treated with thio-TEPA].
Drukin EIa; Smirnov AD; Berlin LB
Klin Med (Mosk); 1970 Dec; 48(12):48-52. PubMed ID: 4996609
[No Abstract] [Full Text] [Related]
11. [Study of the hemo-stimulating effect of zymosan according to findings in the blood and bone marrow of normal subjects and experimental animals with tumors during their treatment with thio-TEPA].
Prane LIu; Bass-Shadkhan KhF
Klin Lech Zlokach Novoobraz; 1968; 11():249-55. PubMed ID: 4972955
[No Abstract] [Full Text] [Related]
12. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
Thiele J; Funke S; Holgado S; Choritz H; Georgii A
Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964
[TBL] [Abstract][Full Text] [Related]
13. [Plateletpheresis in primary thrombocythemia].
Suzuki K; Asano Y; Yokoyama S; Tomoyasu S; Nunogami N
Rinsho Ketsueki; 1982 Oct; 23(10):1661-7. PubMed ID: 7154265
[No Abstract] [Full Text] [Related]
14. Control of thrombocytosis by plateletpheresis using a cell separator.
Beard ME; Blacklock HA; Varcoe AR
N Z Med J; 1980 Feb; 91(654):136-8. PubMed ID: 6929973
[TBL] [Abstract][Full Text] [Related]
15. [ON HISTOCHEMICAL CHANGES IN THE KARYOCYTES OF RED BONE MARROW OF WHITE RATS FOLLOWING THE ADMINISTRATION OF THIO-TEPA].
VERENIKINA BI
Tr Leningr Sanitarnogig Med Inst; 1963; 76():168-71. PubMed ID: 14103155
[No Abstract] [Full Text] [Related]
16. Rapid reduction of platelet numbers in thrombocytosis.
Liumbruno G; Centoni PE; Ceretelli S; Sodini ML
Ther Apher; 2000 Oct; 4(5):374-6. PubMed ID: 11111819
[TBL] [Abstract][Full Text] [Related]
17. Long-term plateletpheresis in the management of primary thrombocytosis.
Goldfinger D; Thompson R; Lowe C; Kurz L; Belkin G
Transfusion; 1979; 19(3):336-8. PubMed ID: 452073
[TBL] [Abstract][Full Text] [Related]
18. Platelet apheresis for digital gangrene due to thrombocytosis in chronic myeloid leukaemia.
Win N; Mitchell DC
Clin Lab Haematol; 2001 Feb; 23(1):65-6. PubMed ID: 11422234
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of thio-TEPA and TEPA in the conventional dose-range and its correlation to myelosuppressive effects.
Hagen B
Cancer Chemother Pharmacol; 1991; 27(5):373-8. PubMed ID: 1705489
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic thrombocytapheresis for extreme thrombocytosis after chemotherapy in essential thrombocytosis.
Almeida-Dias R; Garrote M; Cid J; Mustieles MJ; Alba C; Lozano M
J Clin Apher; 2019 Aug; 34(4):503-506. PubMed ID: 30624802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
